Effect of fingolimod on circulating B cells in patients with multiple sclerosis

被引:0
|
作者
Miyazaki, Y. [1 ]
Niino, M. [1 ]
Fukazawa, T. [2 ]
Nonaka, T. [1 ]
Amino, I. [1 ]
Tashiro, J. [1 ]
Minami, N. [1 ]
Fujiki, N. [1 ]
Doi, S. [1 ]
Kikuchi, S. [1 ]
机构
[1] Hokkaido Med Ctr, Sapporo, Hokkaido, Japan
[2] Sapporo Neurol Clin, Sapporo, Hokkaido, Japan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:217 / 217
页数:1
相关论文
共 50 条
  • [41] Effect of Fingolimod and Interferon β-1α in Children With Multiple Sclerosis
    Zhao, Ying
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (01) : E99 - E101
  • [42] High expression of cytotoxic molecules and Th1 bias of circulating T cells in patients with multiple sclerosis under fingolimod treatment
    Fujii, Chihiro
    Okada, Yoichiro
    Kimura, Kimitoshi
    Nakagawa, Masanori
    Matsumoto, Sadayuki
    Takahashi, Ryosuke
    Ochi, Hirofumi
    Kondo, Takayuki
    Mizuno, Toshiki
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 199 - 199
  • [43] Clinical experience with fingolimod in pediatric multiple sclerosis patients
    Meca-Lallana, V.
    Aguirre, C.
    Diaz, C.
    Cantarin, V.
    Del Rio, B.
    Vivancos, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 626 - 627
  • [44] Fingolimod reduces circulating tight-junction protein levels and in vitro peripheral blood mononuclear cells migration in multiple sclerosis patients
    Pasquale Annunziata
    Chiara Cioni
    Gianni Masi
    Maristella Tassi
    Giuseppe Marotta
    Sauro Severi
    Scientific Reports, 8
  • [45] Fingolimod reduces circulating tight-junction protein levels and in vitro peripheral blood mononuclear cells migration in multiple sclerosis patients
    Annunziata, Pasquale
    Cioni, Chiara
    Masi, Gianni
    Tassi, Maristella
    Marotta, Giuseppe
    Severi, Sauro
    SCIENTIFIC REPORTS, 2018, 8
  • [46] Gait improvement in multiple sclerosis patients treated with fingolimod
    Eichau, S.
    Perez-Sanchez, S.
    Escudero-Uribe, S.
    Hochsprung, A.
    Geniz, M. A.
    Navarro-Mascarell, G.
    Izquierdo-Ayuso, G.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 589 - 589
  • [47] Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients
    Ferraro, Diana
    De Biasi, Sara
    Simone, Anna Maria
    Orlandi, Riccardo
    Nasi, Milena
    Vitetta, Francesca
    Pinti, Marcello
    Fogliani, Marco
    Meletti, Stefano
    Cossarizza, Andrea
    Sola, Patrizia
    CELLS, 2021, 10 (12)
  • [48] Withdrawal Rebound after Fingolimod in Multiple Sclerosis Patients
    Gunduz, Tuncay
    Kurtuncu, Murat
    Eraksoy, Mefkure
    NEUROLOGY, 2016, 86
  • [49] Initiating oral fingolimod treatment in patients with multiple sclerosis
    Singer, Barry A.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2013, 6 (04) : 269 - 275
  • [50] Fingolimod Suppresses Bone Resorption in Patients with Multiple Sclerosis
    Miyazaki, Yusei
    Niino, Masaaki
    Kanazawa, Ippei
    Suzuki, Masako
    Mizuno, Masanori
    Hisahara, Shin
    Fukazawa, Toshiyuki
    Takahashi, Eri
    Amino, Itaru
    Ochi, Ryutaro
    Minami, Naoya
    Fujiki, Neoto
    Doi, Shizuki
    Kikuchi, Seiji
    NEUROLOGY, 2016, 86